WILBUR LEO WATCH Details of the spectacular workings of the WILBUR LEO watch movement NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) — Wilbur Watch Co. is proud to announce that it has been voted the 2024 American Watch Brand of the Year at the prestigious WatchPro Awards in New York City. This esteemed award recognizes the innovative craftsmanship, forward-thinking […]
AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies
AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in […]
AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies
AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in […]
AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies
AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in […]
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]